Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors associated with a better response to the Japanese aluminum-free hepatitis A vaccine, Aimmugen® , for people living with HIV.
Koga M, Senkoji T, Kubota M, Ishizaka A, Mizutani T, Sedohara A, Ikeuchi K, Kikuchi T, Adachi E, Saito M, Koibuchi T, Hosomichi K, Ohashi J, Kawana-Tachikawa A, Matano T, Tsutsumi T, Yotsuyanagi H. Koga M, et al. Among authors: koibuchi t. Hepatol Res. 2022 Mar;52(3):227-234. doi: 10.1111/hepr.13736. Epub 2021 Dec 20. Hepatol Res. 2022. PMID: 34825436
Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults.
Kikuchi T, Iwatsuki-Horimoto K, Adachi E, Koga M, Nakamura H, Hosoya N, Kawana-Tachikawa A, Koibuchi T, Miura T, Fujii T, Kawaoka Y, Iwamoto A. Kikuchi T, et al. Among authors: koibuchi t. Vaccine. 2012 Jun 6;30(26):3819-23. doi: 10.1016/j.vaccine.2012.03.083. Epub 2012 Apr 10. Vaccine. 2012. PMID: 22504038
Reply to Lin et al.
Koibuchi T, Yotsuyanagi H. Koibuchi T, et al. Clin Infect Dis. 2020 Jul 27;71(3):698. doi: 10.1093/cid/ciz1005. Clin Infect Dis. 2020. PMID: 31608403 No abstract available.
Comparison of the Clinical Features of Hepatitis A in People Living with HIV between Pandemics in 1999-2000 and 2017-2018 in the Metropolitan Area of Japan.
Koga M, Lim LA, Ogishi M, Satoh H, Kikuchi T, Adachi E, Sugiyama R, Kiyohara T, Suzuki R, Muramatsu M, Koibuchi T, Tsutsumi T, Yotsuyanagi H. Koga M, et al. Among authors: koibuchi t. Jpn J Infect Dis. 2020 Mar 24;73(2):89-95. doi: 10.7883/yoken.JJID.2019.275. Epub 2019 Oct 31. Jpn J Infect Dis. 2020. PMID: 31666497 Free article.
Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
Ishizaka A, Koga M, Mizutani T, Parbie PK, Prawisuda D, Yusa N, Sedohara A, Kikuchi T, Ikeuchi K, Adachi E, Koibuchi T, Furukawa Y, Tojo A, Imoto S, Suzuki Y, Tsutsumi T, Kiyono H, Matano T, Yotsuyanagi H. Ishizaka A, et al. Among authors: koibuchi t. Microbiol Spectr. 2021 Sep 3;9(1):e0070821. doi: 10.1128/Spectrum.00708-21. Epub 2021 Aug 11. Microbiol Spectr. 2021. PMID: 34378948 Free PMC article.
Long-term successful control of super-multidrug-resistant human immunodeficiency virus type 1 infection by a novel combination therapy of raltegravir, etravirine, and boosted-darunavir.
Nakamura H, Miyazaki N, Hosoya N, Koga M, Odawara T, Kikuchi T, Koibuchi T, Kawana-Tachikawa A, Fujii T, Miura T, Iwamoto A. Nakamura H, et al. Among authors: koibuchi t. J Infect Chemother. 2011 Feb;17(1):105-10. doi: 10.1007/s10156-010-0082-4. Epub 2010 Jun 30. J Infect Chemother. 2011. PMID: 20585968
69 results